139 related articles for article (PubMed ID: 12393549)
1. Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation.
Roelofs H; de Pauw ES; Zwinderman AH; Opdam SM; Willemze R; Tanke HJ; Fibbe WE
Blood; 2003 Jan; 101(1):358-62. PubMed ID: 12393549
[TBL] [Abstract][Full Text] [Related]
2. Limited telomere shortening in hematopoietic stem cells after transplantation.
Brümmendorf TH; Rufer N; Baerlocher GM; Roosnek E; Lansdorp PM
Ann N Y Acad Sci; 2001 Jun; 938():1-7; discussion 7-8. PubMed ID: 11458496
[TBL] [Abstract][Full Text] [Related]
3. Telomere length changes after umbilical cord blood transplant.
Pipes BL; Tsang T; Peng SX; Fiederlein R; Graham M; Harris DT
Transfusion; 2006 Jun; 46(6):1038-43. PubMed ID: 16734822
[TBL] [Abstract][Full Text] [Related]
4. Influence of telomere length on short-term recovery after allogeneic stem cell transplantation.
Widmann TA; Willmann B; Pfreundschuh M; Beelen DW
Exp Hematol; 2005 Oct; 33(10):1257-61. PubMed ID: 16219549
[TBL] [Abstract][Full Text] [Related]
5. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
[TBL] [Abstract][Full Text] [Related]
6. In vivo telomere dynamics of human hematopoietic stem cells.
Notaro R; Cimmino A; Tabarini D; Rotoli B; Luzzatto L
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13782-5. PubMed ID: 9391104
[TBL] [Abstract][Full Text] [Related]
7. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion.
de Pauw ES; Otto SA; Wijnen JT; Vossen JM; van Weel MH; Tanke HJ; Miedema F; Willemze R; Roelofs H; Fibbe WE
Br J Haematol; 2002 Feb; 116(2):491-6. PubMed ID: 11841457
[TBL] [Abstract][Full Text] [Related]
10. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
[TBL] [Abstract][Full Text] [Related]
11. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
[TBL] [Abstract][Full Text] [Related]
12. Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
Widmann T; Kneer H; König J; Herrmann M; Pfreundschuh M
Exp Hematol; 2008 Jan; 36(1):104-10. PubMed ID: 17949890
[TBL] [Abstract][Full Text] [Related]
13. Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant.
Robertson JD; Testa NG; Russell NH; Jackson G; Parker AN; Milligan DW; Stainer C; Chakrabarti S; Dougal M; Chopra R
Bone Marrow Transplant; 2001 Jun; 27(12):1283-6. PubMed ID: 11548846
[TBL] [Abstract][Full Text] [Related]
14. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
Lee J; Kook H; Chung I; Kim H; Park M; Kim C; Nah J; Hwang T
Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy.
Szyper-Kravitz M; Uziel O; Shapiro H; Radnay J; Katz T; Rowe JM; Lishner M; Lahav M
Br J Haematol; 2003 Jan; 120(2):329-36. PubMed ID: 12542495
[TBL] [Abstract][Full Text] [Related]
16. In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency.
Selleri S; Brigida I; Casiraghi M; Scaramuzza S; Cappelli B; Cassani B; Ferrua F; Aker M; Slavin S; Scarselli A; Cancrini C; Marktel S; Grazia Roncarolo M; Aiuti A
J Allergy Clin Immunol; 2011 Jun; 127(6):1368-75.e8. PubMed ID: 21477850
[TBL] [Abstract][Full Text] [Related]
17. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor.
Gyger M; Stuart RK; Perreault C
Bone Marrow Transplant; 2000 Jul; 26(1):1-16. PubMed ID: 10918400
[TBL] [Abstract][Full Text] [Related]
18. Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation.
Lahav M; Uziel O; Kestenbaum M; Fraser A; Shapiro H; Radnay J; Szyper-Kravitz M; Avihai S; Hardan I; Shem-Tov N; Nagler A
Transplantation; 2005 Oct; 80(7):969-76. PubMed ID: 16249747
[TBL] [Abstract][Full Text] [Related]
19. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
20. Marked telomere fluctuation of leukocytes during graft-versus-host disease in allogeneic stem cell transplantation.
Sashida G; Ohyashiki JH; Kubota N; Shoji N; Ishii Y; Tauchi T; Kimura Y; Shay JW; Ohyashiki K
Int J Mol Med; 2005 Nov; 16(5):883-8. PubMed ID: 16211259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
